From September 4th to 6th, 2023, the renowned RWTH Aachen hosted the 5th Conference on Impedance-Based Cellular Assays (IBCA). This significant event was organized by Professor Sven Ingebrandt, Head of the RWTH Institute for Materials in Electrical Engineering 1, and Professor Joachim Wegener from the Institute of Analytical Chemistry at the University of Regensburg. The conference gathered participants from Europe, the USA, South America, and Asia to exchange knowledge and discuss advancements in impedance-based cellular assays. These assays utilize electrical measurements to study the growth of human cells and are increasingly important in regenerative medicine.
Global experts unite to discuss cutting-edge impedance-based cellular assays
This three-day conference brought together experts from Europe, the USA, South America, and Asia to discuss the latest advancements and technologies in impedance-based cellular assays. These innovative methods utilize electrical measurements to monitor the growth of human cells and are increasingly valuable in the field of regenerative medicine.
Advancing Cell-Based Therapies: Restoring Lost Functions
The Conference on Impedance-Based Cellular Assays (IBCA) at RWTH Aachen focused on the development of methods to restore physical functions lost due to diseases or injuries. By analyzing cell growth in detail, researchers can develop innovative therapies to combat neurodegenerative diseases such as Parkinson’s or Alzheimer’s, diabetes mellitus, heart diseases, and cancer.
Impedance-Based Cellular Assays: Analyzing Drug Effects on Biological Barriers
Impedance-based cellular assays provide a valuable tool for analyzing the effects of drugs on the biological barrier properties of skin cells, the blood-brain barrier, and nerve cells. This allows for a more targeted and effective development of medications and medical devices that are tailored to the specific needs of patients.
Results of conference drive development of innovative therapies and medical products
The outcomes of the conference play a significant role in advancing the development of groundbreaking therapies and novel medical devices. The impedance-based cellular assays hold immense potential in combating diseases that are currently considered incurable, providing hope for patients and healthcare professionals alike.
By utilizing impedance-based cellular assays, researchers are able to accurately analyze cell growth and investigate the effects of pharmaceuticals. This enables the development of personalized treatments that cater to the specific needs of individual patients.
The 5th Conference on Impedance-Based Cellular Assays provided compelling evidence of the significant advancements made in regenerative medicine. Through the utilization of impedance-based cellular techniques, a new era of treatment possibilities has emerged, offering hope to individuals worldwide. The ongoing development of this revolutionary technology promises to deliver groundbreaking therapies in the future, making it an exciting field to watch.
Contact: RWTH Institute of Materials in Electrical Engineering 1, Contact person: Professor Sven Ingebrandt, Address: Mies-van-der-Rohe-Straße 15, 52074 Aachen, Phone: +49 241 80-XXXX, Email: email@example.com